Epidemiology of Primary Brain Tumors in the Province of Catania during the 2003–2016 Period

2021 ◽  
Vol 55 (6) ◽  
pp. 473-483
Author(s):  
Chaima Chebil ◽  
Farid Boumediene ◽  
Calogero E. Cicero ◽  
Cristina Rascunà ◽  
Alessia Di Prima ◽  
...  
Keyword(s):  
Brain Tumors ◽  
Malignant Tumors ◽  
Age Groups ◽  
International Classification Of Diseases ◽  
Epidemiological Studies ◽  
Primary Brain Tumors ◽  
Male Ratio ◽  
Classification Of Diseases ◽  
Log Linear

<b><i>Introduction:</i></b> Primary brain tumors (PBTs) account for approximately 2% of all cancers and are associated with significant morbidity and mortality. However, only few epidemiological studies focus on PBTs in Italy. The aim of this study was to evaluate incidence, temporal trend, and survival rate of all PBTs in the province of Catania during the study period. <b><i>Methods:</i></b> All patients diagnosed with PBTs in the province of Catania during the 2003-2016 were identified through the local cancer registry. All cases were classified by histology according to 2007 WHO classification of central nervous system tumors, using the International Classification of Diseases for Oncology, 3rd edition codes. The incidence rate (IR) was calculated for all PBTs and by gender, histology, age-groups, and behavior. Trend analysis was performed using a piecewise log-linear model. <b><i>Results:</i></b> A total of 3,819 cases were identified with a female/male ratio of 1.45. The IR for all PBTs was 25.3/100,000 person-years (95% confidence interval 24.5–26.1). Most PBTs were nonmalignant (59.5%, IR = 15.0) with a female predominance. Conversely, malignant tumors (32.4%, IR = 8.2) were more common among men, with a female/male ratio of 0.9. The most frequently reported histology was meningioma (39.0%, IR = 9.8), followed by glioblastoma (11.6%, IR = 2.9). A peak of incidence was found in the 75–84 years age-group, with an IR of 77.6/100,000 person-years. Overall, no increase in incidence was observed along the study period. <b><i>Conclusions:</i></b> The IR of PBTs in the province of Catania is close to incidence reported worldwide. Further studies on risk factors are necessary.

Association of age with risk of major depression among patients with chronic kidney disease over midlife: a nationwide cohort study in Taiwan

2018 ◽  
Vol 31 (08) ◽  
pp. 1171-1179 ◽  
Author(s):  
Shih-Feng Chen ◽  
Yu-Huei Chien ◽  
Pau-Chung Chen ◽  
I-Jen Wang
Keyword(s):  
Chronic Kidney Disease ◽  
Cohort Study ◽  
Major Depression ◽  
Kidney Disease ◽  
Comparison Group ◽  
Age Groups ◽  
International Classification Of Diseases ◽  
Classification Of Diseases ◽  
The Impact

ABSTRACTBackground:The impact of age on the development of depression among patients with chronic kidney disease (CKD) at stages before dialysis is not well known. We aimed to explore the incidence of major depression among predialysis CKD patients of successively older ages through midlife.Methods:We conducted a retrospective cohort study using the longitudinal health insurance database 2005 in Taiwan. This study investigated 17,889 predialysis CKD patients who were further categorized into study (i.e. middle and old-aged) groups and comparison group aged 18–44. The International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) was applied for coding diseases.Results:The group aged 75 and over had the lowest (hazard ratio [HR] 0.47; 95% confidence interval [CI] 0.32–0.69) risk of developing major depression, followed by the group aged 65–74 (HR 0.67; 95% CI 0.49–0.92), using the comparison group as reference. The adjusted survival curves showed significant differences in cumulative major depression-free survival between different age groups. We observed that the risk of major depression development decreases with higher age. Females were at a higher risk of major depression than males among predialyasis CKD patients.Conclusions:The incidence of major depression declines with higher age in predialysis CKD patients over midlife. Among all age groups, patients aged 75 and over have the lowest risk of developing major depression. A female preponderance in major depression development is present. We suggest that depression prevention and therapy should be integrated into the standard care for predialysis CKD patients, especially for those young and female.

Incidence of Football Injuries and Complaints in Different Age Groups and Skill-Level Groups

2000 ◽  
Vol 28 (5_suppl) ◽  
pp. 51-57 ◽  
Author(s):  
Lars Peterson ◽  
Astrid Junge ◽  
Jiri Chomiak ◽  
Toni Graf-Baumann ◽  
Jiri Dvorak
Keyword(s):  
Continuing Education ◽  
Age Groups ◽  
International Classification Of Diseases ◽  
Fair Play ◽  
Skill Levels ◽  
Subsequent Performance ◽  
Classification Of Diseases ◽  
Icd 10 ◽  
Over Time

In this study, the incidence of football injuries and complaints as related to different age groups and skill levels was studied over the period of 1 year. All injuries and complaints as well as the amount of time players spent in training and games were recorded. All injured players were examined weekly by physicians, and all injuries were assessed according to the International Classification of Diseases (ICD-10), which describes them in terms of injury type and location, the treatment required, and the duration of subsequent performance limitations. A total of 264 players of different age groups and skill levels was observed for 1 year. Five hundred fifty-eight injuries were documented. Two hundred sixteen players had one or more injuries. Only 48 players (18%) had no injury. The average number of injuries per player per year was 2.1. Injuries were classified as mild (52%), moderate (33%), or severe (15%). Almost 50% of all injuries were contact injuries; half of all the contact injuries were associated with foul play. The majority of injuries were strains and sprains involving the ankle, knee, and lumbar spine. Nearly all players (91%) suffered from complaints related to football. Only 23 players reported no injuries and no complaints. Prevention programs, fair play, and continuing education in techniques and skills may reduce the incidence of injuries over time.

scholarly journals A rheumatoid arthritis okozta országos epidemiológiai és egészségbiztosítási betegségteher Magyarországon

2021 ◽  
Vol 162 (Supplement-1) ◽  
pp. 30-37
Author(s):  
Diána Elmer ◽  
Dóra Endrei ◽  
Andor Sebestyén ◽  
Tímea Csákvári ◽  
Noémi Németh ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Health Insurance ◽  
Treatment Cost ◽  
Age Groups ◽  
International Classification Of Diseases ◽  
Cost Driver ◽  
Insurance Fund ◽  
Main Diagnosis ◽  
Classification Of Diseases

Összefoglaló. Bevezetés: A rheumatoid arthritisszel kapcsolatos szolgáltatások igénybevétele nagy teher az egészségügyi rendszerek számára. Célkitűzés: Elemzésünk célja volt a rheumatoid arthritis okozta éves epidemiológiai és egészségbiztosítási betegségteher meghatározása Magyarországon. Adatok és módszerek: Az elemzésben felhasznált adatok a Nemzeti Egészségbiztosítási Alapkezelő (NEAK) finanszírozási adatbázisából származnak, és a 2018. évet fedik le. Meghatároztuk az éves betegszámokat, a prevalenciát 100 000 lakosra, továbbá az éves egészségbiztosítási kiadásokat korcsoportos és nemenkénti bontásban valamennyi egészségbiztosítási ellátás tekintetében. A rheumatoid arthritis kórképet fődiagnózisként a Betegségek Nemzetközi Osztályozása (BNO, 10. revízió) szerinti M0690-es kóddal azonosítottuk. Eredmények: Meghatározó betegforgalmat a gyógyszerek ártámogatása esetében találtunk: 7015 férfi, 23 696 nő, együtt 30 711 fő. A gyógyszer-ártámogatás betegforgalmi adatai alapján a 100 000 főre eső prevalencia férfiaknál 150,2 fő, nőknél 464,0 fő, együtt 314,1 fő volt. A rheumatoid arthritis kezelésére a NEAK 1,64 milliárd Ft-ot (6,07 millió USD, illetve 5,14 millió EUR) költött 2018-ban. A kiadások 19,3%-a férfiaknál, míg 80,7%-a nőknél jelenik meg. A gyógyszer-ártámogatás (az összes kiadás 42,8%-a), a járóbeteg-szakellátás (21,9%) és az aktívfekvőbeteg-szakellátás (12,4%) voltak a meghatározó költségelemek. Az egy betegre jutó átlagos éves egészségbiztosítási kiadás 53 375 Ft (198 USD/167 EUR) volt. Következtetés: A gyógyszerek ártámogatása bizonyult a fő költségtényezőnek. A rheumatoid arthritis előfordulási gyakorisága 3,1-szer magasabb a nők esetében a férfiakhoz képest. Orv Hetil. 2021; 162(Suppl 1): 30–37. Summary. Introduction: Utilisation of services related to the treatment of rheumatoid arthritis poses a great burden for healthcare systems. Objecive: Our aim was to determine the annual epidemiological disease burden and the health insurance treatment cost of rheumatoid arthritis in Hungary. Data and methods: Data were derived from the financial database of the National Health Insurance Fund Administration (NHIFA) of Hungary, for the year 2018. The data analysed included annual patient numbers and prevalence per 100 000 population and annual health insurance treatment costs calculated for age groups and sex according to all health insurance treatment categories. Patients with rheumatoid arthritis were identified as main diagnosis with the following code of the International Classification of Diseases, 10th revision: M0690. Results: We found a significant patient turnover in pharmaceutical reimbursement: 7015 men, 23 696 women, in total 30 711 patients. Based on patient numbers in pharmaceuticals, prevalence for 100 000 population among men was 150.2 patients, among women 464.0, in total 314.1 patients. In 2018, NHIFA spent 1.64 billion HUF (6.07 million USD, 5.14 million EUR) on the treatment of patients with rheumatoid arthritis. 19.3% of the costs was spent on the treatment of male, 80.7% on female patients. Pharmaceuticals (42.8% of the total expenditures), outpatient care (21.9%) and acute inpatient care (12.4%) were the main cost drivers. Average annual health insurance treatment cost per patient was 53 375 HUF (198 USD/167 EUR). Conclusion: Pharmaceutical reimbursement was the major cost driver. The prevalence of rheumatoid arthritis was by 3.1 higher in women compared to men. Orv Hetil. 2021; 162(Suppl 1): 30–37.

scholarly journals A kórházi adatlapok jelentéseinek alkalmazhatósága epidemiológiai elemzésekre az ischaemiás cerebrovascularis betegségek példája alapján

2015 ◽  
Vol 156 (38) ◽  
pp. 1540-1546 ◽  
Author(s):  
András Ajtay ◽  
Ferenc Oberfrank ◽  
Dániel Bereczki
Keyword(s):  
Health Care Financing ◽  
International Classification Of Diseases ◽  
Epidemiological Studies ◽  
Insurance Fund ◽  
Cerebral Infarcts ◽  
Hospital Report ◽  
Single Payer ◽  
Classification Of Diseases ◽  
Icd 10

Introduction: In single-payer health care financing systems data extracted from hospital report forms submitted for reimbursement purposes may be used for epidemiological investigations. Aim: Based on data submitted by 14 neurological wards in Central Hungary the authors examined the reliability of these reports. Method: Analyses were performed for the 3-digit codes of the 10th version of the International Classification of Diseases for cerebral infarcts (ICD-10 I63+I64) reported for the National Health Insurance Fund. Results: The number of cases in individual hospitals changed between a decrease by 35% and an increase by 73% from the first to the second half of the year 2012, reflecting changes in the size of the catchment area of the hospitals in July 2012. Of those with an ICD-10 I63 or I64 discharge diagnosis 54–84% had acute stroke. Neurological wards cared for 34–98% of all stroke patients. The diagnoses submitted for reimbursement purposes corresponded in over 99% to the diagnoses in the hospital discharge reports. Inaccuracies occurred in a larger proportion (about 20%) in coding the DRG financing categories. Conclusions: Databases created from hospital reports submitted for reimbursement purposes can be used reliably in Hungary for stroke epidemiological studies. Orv. Hetil., 2015, 156(38), 1540–1546.

scholarly journals Diagnostic classification of psychiatric disorders and familial-genetic research

1999 ◽  
Vol 1 (3) ◽  
pp. 191-196
Keyword(s):  
Psychiatric Disorders ◽  
Genetic Research ◽  
International Classification Of Diseases ◽  
Epidemiological Studies ◽  
Classification Systems ◽  
Detailed Knowledge ◽  
Diagnostic And Statistical Manual ◽  
Classification Of Diseases ◽  
Icd 10

The validity of diagnostic definitions in psychiatry is directly related to the extent to which their etiology can be specified. However, since detailed knowledge of causal or susceptibility factors is lacking for most psychiatric disorders with a known or suspected familial-genetic origin, the current widely accepted classification systems largely fail to achieve this ideal. To illustrate this problem, this paper looks at the difficulties posed by the criteria for schizophrenia as laid down in the International Classification of Diseases, 10th revision (ICD-10) and the Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised (DSM-III-R), and highlights the discrepancies between the majority of diagnostic boundaries and the various phenotype aggregation patterns observed in family studies. Progress in our understanding of psychiatric disorders requires to be firmly based on the findings of epidemiological studies as well as on a clear appreciation of the limitations of classification tools.

General provisions and features of statistical records of the upper respiratory tract diseases, ear and mastoid process in children

2020 ◽  
Vol 40 (4) ◽  
pp. 61-69
Author(s):  
S. O. Samusenko ◽  
◽  
O. I. Serdyuk ◽  
I. V. Filatova ◽  
◽  
...  
Keyword(s):  
Respiratory Tract ◽  
Age Groups ◽  
International Classification Of Diseases ◽  
Mastoid Process ◽  
Upper Respiratory Tract ◽  
Classification Of Diseases ◽  
Icd 10 ◽  
Upper Respiratory ◽  
Statistical Trends

The formation of medical statistical information and the effectiveness of statistical records of diseases of the upper respiratory tract, ear and mastoid process in children on the basis of the current International Classification of Diseases, 10th revision (ICD-10). The relevance of the analysis of the completeness and effectiveness of statistical records of the incidence of diseases of the upper respiratory tract, ear and mastoid process is substantiated. It is established that the reporting of the incidence of the child population on upper respiratory tract, ear and mastoid process is carried out in accordance with the headings of the ICD-10 revision. The requirements of the ICD-11 revision do not make significant changes in the statistical records. Features of statistical records of diseases of the upper respiratory tract, ear and mastoid process on the basis of the modern classifier of diseases — ICD-10 are shown and characterized. The shortcomings of statistical records of diseases of the ear and mastoid process in children in terms of clinical assessment of cases. The reasons of probable underestimation of statistical indicators of incidence of diseases of the upper respiratory tract in this category of patients are analyzed. The presence of differences in the formation of groups of statistical accounting of the incidence of the ear, nose and throat organs in children during the analysis of statistical trends has been proved. It is concluded that this contributes to the inaccuracy of accounting and data analysis, which hinders the development of adequate management decisions. It is shown the expediency of developing indicators, bringing into line the criteria for the formation of age groups for statistical records and creating a single register of nosology for such records at different levels.

scholarly journals Mumps epidemiology in Germany 2007-11

2013 ◽  
Vol 18 (33) ◽  
Author(s):  
A Takla ◽  
O Wichmann ◽  
C Klinc ◽  
W Hautmann ◽  
T Rieck ◽  
...  
Keyword(s):  
Age Groups ◽  
International Classification Of Diseases ◽  
Federal States ◽  
Classification Of Diseases ◽  
Icd 10 ◽  
Outpatient Sector ◽  
Available Information ◽  
Notification Data ◽  
Insurance Data

In Germany, mumps has been notifiable until 2013 only in the five Eastern federal states (EFS) of former East Germany. Due to different immunisation policies until 1990 and varying vaccination coverages thereafter, mumps incidences cannot be extrapolated to the 11 Western federal states (WFS). We studied mumps-related International Classification of Diseases (ICD-10) code diagnoses claimed through statutory health insurances between 2007 and 2011 to estimate countrywide mumps incidences in the outpatient sector, and compared them with case numbers from ambulatory notification data. Overall, 32,330 outpatient mumps cases were claimed. Annual incidence ranged between 9.3/100,000 and 11.8/100,000 and showed a significant decreasing trend. Compared with EFS, mumps incidence in WFS was higher and indicated a shift towards older age groups. Notified outpatient case numbers in EFS were 13-fold lower and from voluntary surveillance during an outbreak in the WFS Bavaria 8-fold lower than from insurance data (n=316 versus n=4,217 and n=238 versus 1,995, respectively). Of all notified cases with available information, 75.4% (EFS) and 57.6% (Bavaria) were unvaccinated; 6.8% (EFS) and 19.3% (Bavaria) required hospitalisation. In Germany, mumps is still endemic despite decades of vaccination, with considerable underreporting in the established notification systems.

scholarly journals Outcome Assessment in Epidemiological Studies of Low-Dose Radiation Exposure and Cancer Risks: Sources, Level of Ascertainment, and Misclassification

2020 ◽  
Vol 2020 (56) ◽  
pp. 154-175 ◽  
Author(s):  
Martha S Linet ◽  
Mary K Schubauer-Berigan ◽  
Amy Berrington de González
Keyword(s):  
Outcome Assessment ◽  
Low Dose ◽  
International Classification Of Diseases ◽  
Epidemiological Studies ◽  
Cancer Risks ◽  
Low Dose Radiation ◽  
Loss To Follow Up ◽  
Classification Of Diseases

Abstract Background Outcome assessment problems and errors that could lead to biased risk estimates in low-dose radiation epidemiological studies of cancer risks have not been systematically evaluated. Methods Incidence or mortality risks for all cancers or all solid cancers combined and for leukemia were examined in 26 studies published in 2006–2017 involving low-dose (mean dose ≤100 mGy) radiation from environmental, medical, or occupational sources. We evaluated the impact of loss to follow-up, under- or overascertainment, outcome misclassification, and changing classifications occurring similarly or differentially across radiation dose levels. Results Loss to follow-up was not reported in 62% of studies, but when reported it was generally small. Only one study critically evaluated the completeness of the sources of vital status. Underascertainment of cancers (“false negatives”) was a potential shortcoming for cohorts that could not be linked with high-quality population-based registries, particularly during early years of exposure in five studies, in two lacking complete residential history, and in one with substantial emigration. False positives may have occurred as a result of cancer ascertainment from self- or next-of-kin report in three studies or from enhanced medical surveillance of exposed patients that could lead to detection bias (eg, reporting precancer lesions as physician-diagnosed cancer) in one study. Most pediatric but few adult leukemia studies used expert hematopathology review or current classifications. Only a few studies recoded solid cancers to the latest International Classification of Diseases or International Classification of Diseases for Oncology codes. These outcome assessment shortcomings were generally nondifferential in relation to radiation exposure level except possibly in four studies. Conclusion The majority of studies lacked information to enable comprehensive evaluation of all major sources of outcome assessment errors, although reported data suggested that the outcome assessment limitations generally had little effect on risk or biased estimates towards the null except possibly in four studies.

scholarly journals International Analysis of Age-Specific Mortality Rates From Mesothelioma on the Basis of the International Classification of Diseases, 10th Revision

2018 ◽  
pp. 1-15 ◽  
Author(s):  
Paolo Boffetta ◽  
Matteo Malvezzi ◽  
Enrico Pira ◽  
Eva Negri ◽  
Carlo La Vecchia
Keyword(s):  
United States ◽  
Age Groups ◽  
International Classification Of Diseases ◽  
The United States ◽  
Mortality Rates ◽  
International Classification ◽  
Peritoneal Mesothelioma ◽  
Specific Mortality ◽  
Classification Of Diseases

Past analyses of mortality data from mesothelioma relied on unspecific codes, such as pleural neoplasms. We calculated temporal trends in age-specific mortality rates in Canada, the United States, Japan, France, Germany, Italy, the Netherlands, Poland, the United Kingdom, and Australia on the basis of the 10th version of the International Classification of Diseases, which includes a specific code for mesothelioma. Older age groups showed an increase (in the United States, a weaker decrease) during the study period, whereas in young age groups, there was a decrease (in Poland, a weaker increase, starting, however, from low rates). Results were consistent between men and women and between pleural and peritoneal mesothelioma, although a smaller number of events in women and for peritoneal mesothelioma resulted in less precise results. The results show the heterogeneous effect of the reduction of asbestos exposure on different age groups; decreasing mortality in young people reflects reduced exposure opportunity, and increasing mortality in the elderly shows the long-term effect of early exposures.

Increasing Trends in Some Cancers in Older Americans: Fact or Artifact?

1988 ◽  
Vol 18 (1) ◽  
pp. 35-68
Author(s):  
Devra Lee Davis ◽  
Abraham M. Lilienfeld ◽  
Alan M. Gittelsohn ◽  
Mary Ellen Scheckenbach
Keyword(s):  
Cancer Mortality ◽  
Age Groups ◽  
The Elderly ◽  
International Classification Of Diseases ◽  
Older Americans ◽  
Site Specific ◽  
Specific Cancer ◽  
Classification Of Diseases ◽  
Increasing Trends

In analyzing U.S. cancer mortality from 1933 to 1978, Doll and Peto speculated that recently recorded increases in mortality among those over age 64 were likely to be artifacts, reflecting deaths previously misattributed to such causes as nonspecific cancer, pneumonia, and senility and other ill-defined causes. We test this hypothesis by examining some age-specific, cause-specific mortality in persons aged 35 to 84 for the period of the 8th International Classification of Diseases A, 1968–78, which corresponds to the last 11 years of the period studied by Doll and Peto. Our analysis reveals increasing trends in mortality from lung cancer, brain cancer, and multiple myeloma in older whites and nonwhites, along with increases in several potentially miscoded causes of death from 1968 to 1978. Thus, these increasing cancers in the elderly cannot be explained solely as artifacts. Further studies of trends in site-specific cancer mortality should include age groups through at least age 85. Continued monitoring of site-specific cancer mortality patterns, particularly among the elderly, remains crucial for developing preventive strategies to reduce cancers.

Sign in / Sign up

Export Citation Format

Share Document